Pfizer Inc at Truist Financial AI Symposium - Biotech & Tools Transcript
Hello, and good morning or good afternoon, everyone. My name is Robyn Karnauskas, one of the biotech analysts at Truist Securities. With me, I also have Kripa Devarakonda, also a biotech analyst. And I'd like to welcome you to our keynote presentation at our Truist Securities AI Symposium with Pfizer.
So the title of the talk is Pharma and AI -- is it the future? And this is a real-world case study of how it actually sped up development of the COVID vaccine.
So we'll start off with a presentation by Lidia Fonseca, Pfizer's Chief Digital and Technology Officer, followed by some Q&A. And with that, I will turn it over to Ronen and Lidia to begin the presentation.
Thank you so much, Robyn. It is my obligation to make everybody aware of the fact that we're going to use some forward-looking statements in this presentation, among others about further digital strategy, our response to COVID-19, including
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
